Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial
1 Department of Clinical Medicine, The Faculty of Medicine, Aalborg University, VBN2 The Faculty of Medicine, Aalborg University, VBN3 University of Rochester Medical Center, Heart Research Follow-Up Program, Rochester, NY4 Department of Cardiology, Gentofte Hospital, Hellerup5 Department of Medicine, University of Iowa Health Care, Iowa City6 Klinik Hjerte-Lunge, The Faculty of Medicine, Aalborg University, VBN7 Department of Cardiology, Tokyo Women’s Medical University, Tokyo8 Semmelweis University9 Semmelweis University
The relationship between diabetes mellitus and risk of inappropriate or appropriate therapy in patients receiving an implantable cardioverter-defibrillator (ICD) and resynchronization therapy has not been investigated thoroughly. The effect of innovative ICD programming on therapy delivery in these patients is unknown.
Circulation (baltimore), 2013, Vol 128, Issue 7, p. 694-701